Showing posts with label ombitasvir and dasabuvir (with or without ribavirin). Show all posts
Showing posts with label ombitasvir and dasabuvir (with or without ribavirin). Show all posts
Thursday, November 20, 2014

New treatment regimen for hepatitis C in transplant patients produces promising results

›
The investigational three-drug regimen, which produced hepatitis C cure rates of 97 percent, is an oral interferon-free therapy. Previou...